Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07619391

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreatic Adenocarcinoma

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location status: Recruiting

Location contact

Pamela W. Lu, MD

CONTACT

[email protected]

614-293-7171

Pamela W. Lu, MD

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVE:

I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment.

OUTLINE:

Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults ≥ 18 years old
  • Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
  • English speaking
  • Access to a smartphone (Android or iOS)

Exclusion criteria

  • Prisoners
  • Patients undergoing cancer surveillance

Treatment and study plan

Electronic Health Record Review

Other

Ancillary studies

Smartphone Application-based Intervention

Behavioral

Receive access to MyCap application

Other names: Smartphone App-based Intervention, Smartphone Intervention, Smartphone-based Intervention

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Retention rate (feasibility)

    Time frame: Up to 8 weeks

    Defined as the number of participants who enroll in the study and complete at least one time log during the study period.

  2. Adherence rate (feasibility)

    Time frame: Up to 8 weeks

    Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs.

  3. System usability survey (feasibility)

    Time frame: Up to 8 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

The Ohio State University Comprehensive Cancer Center

CONTACT

[email protected]

800-293-5066

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 2, 2026
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.